JP2022508523A5 - - Google Patents

Info

Publication number
JP2022508523A5
JP2022508523A5 JP2021542086A JP2021542086A JP2022508523A5 JP 2022508523 A5 JP2022508523 A5 JP 2022508523A5 JP 2021542086 A JP2021542086 A JP 2021542086A JP 2021542086 A JP2021542086 A JP 2021542086A JP 2022508523 A5 JP2022508523 A5 JP 2022508523A5
Authority
JP
Japan
Prior art keywords
pyridine
thieno
trifluoromethyl
methylcarbamoyl
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021542086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022508523A (ja
JP7545979B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/054085 external-priority patent/WO2020072504A1/en
Publication of JP2022508523A publication Critical patent/JP2022508523A/ja
Publication of JP2022508523A5 publication Critical patent/JP2022508523A5/ja
Application granted granted Critical
Publication of JP7545979B2 publication Critical patent/JP7545979B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542086A 2018-10-01 2019-10-01 UDPグリコシルトランスフェラーゼ阻害剤としてのチエノ[3,2-b]ピリジン誘導体および使用の方法 Active JP7545979B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862739405P 2018-10-01 2018-10-01
US62/739,405 2018-10-01
PCT/US2019/054085 WO2020072504A1 (en) 2018-10-01 2019-10-01 Thieno[3,2-b]pyridine derivatives as udp glycosyltransferase inhibitors and methods of use

Publications (3)

Publication Number Publication Date
JP2022508523A JP2022508523A (ja) 2022-01-19
JP2022508523A5 true JP2022508523A5 (cg-RX-API-DMAC7.html) 2022-09-07
JP7545979B2 JP7545979B2 (ja) 2024-09-05

Family

ID=68296740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021542086A Active JP7545979B2 (ja) 2018-10-01 2019-10-01 UDPグリコシルトランスフェラーゼ阻害剤としてのチエノ[3,2-b]ピリジン誘導体および使用の方法

Country Status (15)

Country Link
US (1) US11098056B2 (cg-RX-API-DMAC7.html)
EP (1) EP3861000A1 (cg-RX-API-DMAC7.html)
JP (1) JP7545979B2 (cg-RX-API-DMAC7.html)
KR (1) KR102903997B1 (cg-RX-API-DMAC7.html)
CN (1) CN113423711B (cg-RX-API-DMAC7.html)
AU (1) AU2019355870B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021005914A2 (cg-RX-API-DMAC7.html)
CA (1) CA3114722A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021005738A2 (cg-RX-API-DMAC7.html)
IL (1) IL281811B2 (cg-RX-API-DMAC7.html)
MA (1) MA53043B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021003794A (cg-RX-API-DMAC7.html)
SG (1) SG11202102987VA (cg-RX-API-DMAC7.html)
TW (1) TWI821426B (cg-RX-API-DMAC7.html)
WO (1) WO2020072504A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230157981A (ko) * 2021-02-19 2023-11-17 칼비스타 파마슈티컬즈 리미티드 인자 xiia 저해제
EP4483954A1 (en) * 2023-06-29 2025-01-01 Masarykova Univerzita Substituted thieno [3,2-b]pyridines as inhibitors of protein kinases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3763156A (en) * 1970-01-28 1973-10-02 Boehringer Sohn Ingelheim 2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines
US7375125B2 (en) * 1999-08-04 2008-05-20 Ore Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
WO2001010842A2 (en) * 1999-08-04 2001-02-15 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
SI2215094T1 (sl) * 2007-11-15 2016-05-31 Ym Biosciences Australia Pty Ltd N vsebujoče heterociklične spojine
AU2010210426B2 (en) * 2009-02-06 2015-06-11 Imago Pharmaceuticals, Inc. Inhibitors of Jun N-terminal kinase
KR20130131461A (ko) * 2011-03-07 2013-12-03 폰다지오네 텔레톤 Tfeb 변종 및 그의 용도
CA3199430A1 (en) * 2015-01-16 2016-07-21 The General Hospital Corporation Compounds for improving mrna splicing
WO2017112777A1 (en) * 2015-12-22 2017-06-29 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
WO2017192930A1 (en) * 2016-05-05 2017-11-09 Lysosomal Therapeutics Inc. SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
CA3025943A1 (en) 2016-06-10 2017-12-14 Biomarin Pharmaceutical Inc. Ceramide galactosyltransferase inhibitors for the treatment of disease
KR20190070972A (ko) * 2016-11-02 2019-06-21 얀센 파마슈티카 엔.브이. Pde2 억제제로서의 [1,2,4]트리아졸로[1,5-a]피리미딘 유도체
WO2018118838A1 (en) * 2016-12-20 2018-06-28 Biomarin Pharmaceutical Inc. Ceramide galactosyltransferase inhibitors for the treatment of disease
BR112019023109A2 (pt) 2017-05-04 2020-05-26 Glenmark Pharmaceuticals S.A. Composto, composição farmacêutica e método para tratar uma doença, distúrbio, síndrome ou afecção mediada por nadph oxidase em um indivíduo
KR102736865B1 (ko) 2017-06-21 2024-12-03 샤이 테라퓨틱스 엘엘씨 암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물

Similar Documents

Publication Publication Date Title
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
JP2024517693A5 (cg-RX-API-DMAC7.html)
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
US20230098244A1 (en) Substituted indole compounds
US9796711B2 (en) Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use
HRP20210935T1 (hr) Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
JP2014506929A5 (cg-RX-API-DMAC7.html)
JP2021519291A5 (cg-RX-API-DMAC7.html)
JP2021528466A5 (cg-RX-API-DMAC7.html)
JP2018530557A5 (cg-RX-API-DMAC7.html)
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
JP2015522002A5 (cg-RX-API-DMAC7.html)
JP2015523387A5 (cg-RX-API-DMAC7.html)
HRP20250272T1 (hr) Derivati benzimidazola i njihova uporaba
JP2017505327A5 (cg-RX-API-DMAC7.html)
JP2015537010A5 (cg-RX-API-DMAC7.html)
JP2018529743A (ja) N−スルホニル化ピラゾロ[3,4−b]ピリジン−6−カルボキサミドおよび使用法
JP2015504057A5 (cg-RX-API-DMAC7.html)
JP2018500376A5 (cg-RX-API-DMAC7.html)
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP2010524984A5 (cg-RX-API-DMAC7.html)
RU2020129785A (ru) Фармацевтические производные 6,5-гетеробициклического кольца
US11840528B2 (en) Isoxazolyl ether derivatives as GABAA α5 PAM
EP3551627A1 (en) New isoxazolyl ether derivatives as gaba a alpha5 pam
JP2021527099A5 (cg-RX-API-DMAC7.html)